Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
Abstract Juvenile myelomonocytic leukemia (JMML) treatment primarily relies on hematopoietic stem cell transplantation and results in long-term overall survival of 50–60%, demonstrating a need to develop novel treatments. Dysregulation of the non-coding RNA transcriptome has been demonstrated before...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/0585c9174d894b83a10e9c9210ba9f53 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|